Editorial
 THE LICENCE FEE HIKE   
 Wednesday, February 03, 2016 
 The Drug Controller General of India last month issued a draft order proposing a sharp hike in the license fee for pharmacies and drug manufacturing units besides registration fee for domestically manufactured new products and imported pharmaceutical products. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Study results show tristetraprolin reduces inflammation in mice
17:00  [IST]CollPlant announces positive results from final clinical study of VergenixSTR to treat tendinopathy
16:00  [IST]Optovue introduces AngioAnalytics OCTA blood vessel measurement technology
15:00  [IST]Propanc Health files third patent for PRP method to suppresses cancer stem cells
14:00  [IST]ImmunoGen, Merck collaborate on clinical study of mirvetuximab soravtansine in combo with Keytruda to treat ovarian cancer
13:00  [IST]NIH study shows prenatal steroids lower risk of respiratory illness in late preterm infants
more news >>
TOP NEWS
08:00  [IST]Bharat Biotech claims to come out with Zika virus vaccine in 2 years
08:00  [IST]Union govt sees need for Karnataka to step up growth in pharma by capitalizing on $72 billion worth patent expiries
08:00  [IST]State govt to open 68 more blood storage centres to ensure consistent supply of blood in rural areas
08:00  [IST]IPC 68th edition to be held at Vizag in AP from Dec 16 to 18, 2016
08:00  [IST]KPPA’s Parliament March on Feb 24 gets immense support from various pharmacy associations
08:00  [IST]MSF asks Indian & ASEAN member states to reject TPP as it will adversely affect access to medicine
more news >>
YESTERDAY'S NEWS
18:00  [IST]Sanofi appoints Muzammil Mansuri as executive VP, strategy & business development
17:00  [IST]Pharmaron buys UK-based CRO, Quotient Bioresearch
16:45  [IST]Torrent Pharma net zooms by 189%, interim dividend of 400%
16:30  [IST]Cadila Healthcare net moves up by 38% in Q3
16:05  [IST]Biotechnology Summit discusses action plan to accomplish US$ 100 billion target for biotech sector
15:55  [IST]Lupin consolidated net dips by 11.8% in Q3 to Rs.530 cr
more news >>
INTERVIEW  
IDMA taking steps to strengthen and tap biz opportunities for SMEs
S.V. Veerramani, the new president of the Indian Drugs Manufacturers Association (IDMA)
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the Union Health Ministry's move to hike licence fee for medical shop from the existing Rs 3000 to Rs 30,000 justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2015 Saffron Media Pvt. Ltd |